| Year |
Citation |
Score |
| 2020 |
Dashner-Titus EJ, Schilz JR, Simmons KA, Duncan TR, Alvarez SC, Hudson LG. Differential response of human T-lymphocytes to arsenic and uranium. Toxicology Letters. PMID 32866568 DOI: 10.1016/J.Toxlet.2020.08.013 |
0.37 |
|
| 2019 |
Cao AL, Beaver LM, Wong CP, Hudson LG, Ho E. Zinc deficiency alters the susceptibility of pancreatic beta cells (INS-1) to arsenic exposure. Biometals : An International Journal On the Role of Metal Ions in Biology, Biochemistry, and Medicine. PMID 31542844 DOI: 10.1007/S10534-019-00217-0 |
0.338 |
|
| 2019 |
Hudson LG, Cook LS, Grimes MM, Muller CY, Adams SF, Wandinger-Ness A. Dual Actions of Ketorolac in Metastatic Ovarian Cancer. Cancers. 11. PMID 31344967 DOI: 10.3390/Cancers11081049 |
0.342 |
|
| 2019 |
Zhou X, Ding X, Shen J, Yang D, Hudson LG, Liu KJ. Peroxynitrite contributes to arsenic-induced PARP-1 inhibition through ROS/RNS generation. Toxicology and Applied Pharmacology. 114602. PMID 31152818 DOI: 10.1016/J.Taap.2019.114602 |
0.352 |
|
| 2018 |
Hudson LG, Gillette JM, Kang H, Rivera MR, Wandinger-Ness A. Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase. Cancers. 10. PMID 30261690 DOI: 10.3390/Cancers10100358 |
0.386 |
|
| 2018 |
Rivera M, Dominguez D, Pauken C, Romero E, Kenney SR, Shi Y, Lee J, Gillette J, Hudson LG, Wandinger-Ness A. Abstract 3159: Rac1 and Cdc42 as drivers in ovarian cancer metastasis Cancer Research. 78: 3159-3159. DOI: 10.1158/1538-7445.Am2018-3159 |
0.378 |
|
| 2017 |
Peretti AS, Dominguez D, Grimes MM, Hathaway HJ, Prossnitz ER, Rivera MR, Wandinger-Ness A, Kusewitt DF, Hudson LG. The R-enantiomer of ketorolac delays mammary tumor development in mouse mammary tumor virus-polyoma middle T antigen (MMTV-PyMT) mice. The American Journal of Pathology. PMID 29169987 DOI: 10.1016/J.Ajpath.2017.10.018 |
0.337 |
|
| 2017 |
Ding X, Zhou X, Cooper KL, Huestis J, Hudson LG, Liu KJ. Differential sensitivities of cellular XPA and PARP-1 to arsenite inhibition and zinc rescue. Toxicology and Applied Pharmacology. PMID 28552776 DOI: 10.1016/J.Taap.2017.05.031 |
0.338 |
|
| 2017 |
Xu H, Medina S, Lauer FT, Douillet C, Jian Liu K, Hudson LG, Stýblo M, Aleksunes LM, Burchiel SW. Efflux Transporters Regulate Arsenite Induced Genotoxicity in Double Negative and Double Positive T Cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 28472378 DOI: 10.1093/Toxsci/Kfx075 |
0.351 |
|
| 2017 |
Hudson L, Kenney S, Rivera M, Weisend J, Luo L, Ness S, Gillette J, Wandinger-Ness A. Abstract MIP-061: RAC 1 AND CDC42 GTPASES AS REGULATORS OF OVARIAN CANCER PROGRESSION AND NICHE INTERACTIONS Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Ovcasymp16-Mip-061 |
0.421 |
|
| 2016 |
Zhou X, Cooper KL, Huestis J, Xu H, Burchiel SW, Hudson LG, Liu KJ. S-nitrosation on zinc finger motif of PARP-1 as a mechanism of DNA repair inhibition by arsenite. Oncotarget. PMID 27741521 DOI: 10.18632/Oncotarget.12613 |
0.355 |
|
| 2016 |
Xu H, Lauer FT, Liu KJ, Hudson LG, Burchiel SW. Interactive Genotoxicity Induced by Environmentally Relevant Concentrations of Benzo(a)pyrene Metabolites and Arsenite in Mouse Thymus Cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 27503386 DOI: 10.1093/Toxsci/Kfw151 |
0.358 |
|
| 2016 |
Xu H, Lauer FT, Liu KJ, Hudson LG, Burchiel SW. Environmentally Relevant Concentrations of Arsenite and Monomethylarsonous Acid Inhibit IL-7/STAT5 Cytokine Signaling Pathways in Mouse CD3+CD4-CD8- Double Negative Thymus Cells. Toxicology Letters. PMID 26921788 DOI: 10.1016/J.Toxlet.2016.02.014 |
0.305 |
|
| 2016 |
von Maltzan K, Li Y, Rundhaug JE, Hudson LG, Fischer SM, Kusewitt DF. Role of the Slug Transcription Factor in Chemically-Induced Skin Cancer. Journal of Clinical Medicine. 5. PMID 26848699 DOI: 10.3390/Jcm5020021 |
0.413 |
|
| 2016 |
Granados ML, Hudson LG, Luo L, Samudio-Ruiz SL. Abstract 4437: DNA methylation analysis in cisplatin resistant ovarian cancer cells and recurrent ovarian cancer patient samples Cancer Research. 76: 4437-4437. DOI: 10.1158/1538-7445.Am2016-4437 |
0.36 |
|
| 2015 |
Cooper KL, Dashner EJ, Tsosie R, Cho YM, Lewis J, Hudson LG. Inhibition of poly(ADP-ribose)polymerase-1 and DNA repair by uranium. Toxicology and Applied Pharmacology. PMID 26627003 DOI: 10.1016/J.Taap.2015.11.017 |
0.339 |
|
| 2015 |
Oprea TI, Sklar LA, Agola JO, Guo Y, Silberberg M, Roxby J, Vestling A, Romero E, Surviladze Z, Murray-Krezan C, Waller A, Ursu O, Hudson LG, Wandinger-Ness A. Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases. Plos One. 10: e0142182. PMID 26558612 DOI: 10.1371/Journal.Pone.0142182 |
0.332 |
|
| 2015 |
Ezeh PC, Xu H, Lauer FT, Liu KJ, Hudson LG, Burchiel SW. Monomethylarsonous acid (MMA+3) Inhibits IL-7 Signaling in Mouse Pre-B Cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 26518055 DOI: 10.1093/Toxsci/Kfv233 |
0.347 |
|
| 2015 |
Xu H, Zhou X, Wen X, Lauer FT, Liu KJ, Hudson LG, Aleksunes LM, Burchiel SW. Environmentally-Relevant Concentrations of Arsenite Induce Dose-Dependent Differential Genotoxicity Through Poly(ADP-ribose) Polymerase (PARP) Inhibition and Oxidative Stress in Mouse Thymus Cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 26443841 DOI: 10.1093/Toxsci/Kfv211 |
0.345 |
|
| 2015 |
Granados ML, Hudson LG, Samudio-Ruiz SL. Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells. Plos One. 10: e0136893. PMID 26351843 DOI: 10.1371/Journal.Pone.0136893 |
0.398 |
|
| 2015 |
Guo Y, Kenney SR, Muller CY, Adams S, Rutledge T, Romero E, Murray-Krezan C, Prekeris R, Sklar LA, Hudson LG, Wandinger-Ness A. R-ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis. Molecular Cancer Therapeutics. PMID 26206334 DOI: 10.1158/1535-7163.Mct-15-0419 |
0.415 |
|
| 2015 |
Guo Y, Kenney SR, Cook LS, Adams SF, Rutledge T, Romero E, Oprea T, Sklar LA, Bedrick E, Wiggins CL, Kang H, Lomo L, Muller CY, Wandinger-Ness A, Hudson LG. A novel pharmacologic activity of ketorolac for therapeutic benefit in ovarian cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26071482 DOI: 10.1158/1078-0432.Ccr-15-0461 |
0.363 |
|
| 2015 |
Samudio-Ruiz SL, Granados ML, Hudson LG. Abstract B46: Epigenetic alterations associated with platinum resistance in an ovarian cancer cell model Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Pms14-B46 |
0.378 |
|
| 2015 |
Granados ML, Hudson LG, Samudio-Ruiz SL. Abstract B14: Cisplatin induced activation of the epidermal growth factor receptor as a mechanism for epigenetic silencing in ovarian cancer cell platinum resistance Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Pms14-B14 |
0.449 |
|
| 2015 |
Samudio-Ruiz SL, Granados ML, Hudson LG. Abstract POSTER-THER-1427: Epidermal growth factor receptor mediated alterations in DNA methylation associated with the development of platinum resistance in ovarian cancer cells Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-Poster-Ther-1427 |
0.419 |
|
| 2015 |
Hudson L, Kenney S, Guo Y, Adams S, Rutledge T, Muller C, Wandinger-Ness A. Abstract POSTER-BIOL-1320: Rho-family GTPases as therapeutic targets in ovarian cancer Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-Poster-Biol-1320 |
0.381 |
|
| 2015 |
Guo Y, Kenney SR, Sklar LA, Buranda T, Oprea TI, Ursu O, Adams SF, Rutledge T, Muller C, Lomo L, Hudson LG, Wandinger-Ness A. Abstract 4044: R-ketorolac targets Cdc42 and Rac1 GTPases and alters ovarian tumor cell behaviors critical for invasion and metastasis Cancer Research. 75: 4044-4044. DOI: 10.1158/1538-7445.Am2015-4044 |
0.404 |
|
| 2014 |
Shirley SH, Hammiller B, Hansen LA, Crysup B, Hudson LG, Kusewitt DF. Role of the epidermal growth factor receptor in ultraviolet radiation induction of Snail family transcription factors. Journal of Dermatological Science. 76: 149-51. PMID 25278223 DOI: 10.1016/J.Jdermsci.2014.09.001 |
0.353 |
|
| 2014 |
Burchiel SW, Lauer FT, Beswick EJ, Gandolfi AJ, Parvez F, Liu KJ, Hudson LG. Differential susceptibility of human peripheral blood T cells to suppression by environmental levels of sodium arsenite and monomethylarsonous acid. Plos One. 9: e109192. PMID 25271956 DOI: 10.1371/Journal.Pone.0109192 |
0.318 |
|
| 2014 |
Sun X, Zhou X, Du L, Liu W, Liu Y, Hudson LG, Liu KJ. Arsenite binding-induced zinc loss from PARP-1 is equivalent to zinc deficiency in reducing PARP-1 activity, leading to inhibition of DNA repair. Toxicology and Applied Pharmacology. 274: 313-8. PMID 24275069 DOI: 10.1016/J.Taap.2013.11.010 |
0.349 |
|
| 2014 |
Cooper KL, Yager JW, Hudson LG. Melanocytes and keratinocytes have distinct and shared responses to ultraviolet radiation and arsenic. Toxicology Letters. 224: 407-15. PMID 24270004 DOI: 10.1016/J.Toxlet.2013.11.010 |
0.392 |
|
| 2014 |
Samudio-Ruiz SL, Hudson LG. Persistent N-cadherin Expression Induced by Extended Epidermal GrowthFactor Exposure Regulates Multicellular Aggregate Compaction andSensitivity to Cisplatin Medicinal Chemistry. 2014: 1-11. DOI: 10.4172/2161-0444.S1-005 |
0.466 |
|
| 2014 |
Muller C, Hudson LG, Kenney SR, Guo Y, Gaede M, Adams SF, Rutledge T, Wandinger-Ness A. R-ketorolac as a GTPase inhibitor: Phase 0 intraperitoneal pharmacokinetic and biologic activity in ovarian cancer patients Gynecologic Oncology. 133: 56. DOI: 10.1016/J.Ygyno.2014.03.155 |
0.301 |
|
| 2013 |
Wang F, Zhou X, Liu W, Sun X, Chen C, Hudson LG, Jian Liu K. Arsenite-induced ROS/RNS generation causes zinc loss and inhibits the activity of poly(ADP-ribose) polymerase-1. Free Radical Biology & Medicine. 61: 249-56. PMID 23602911 DOI: 10.1016/J.Freeradbiomed.2013.04.019 |
0.368 |
|
| 2013 |
Cooper KL, King BS, Sandoval MM, Liu KJ, Hudson LG. Reduction of arsenite-enhanced ultraviolet radiation-induced DNA damage by supplemental zinc. Toxicology and Applied Pharmacology. 269: 81-8. PMID 23523584 DOI: 10.1016/J.Taap.2013.03.008 |
0.752 |
|
| 2013 |
Hong L, Kenney SR, Phillips GK, Simpson D, Schroeder CE, Nöth J, Romero E, Swanson S, Waller A, Strouse JJ, Carter M, Chigaev A, Ursu O, Oprea T, Hjelle B, ... ... Hudson LG, et al. Characterization of a Cdc42 protein inhibitor and its use as a molecular probe. The Journal of Biological Chemistry. 288: 8531-43. PMID 23382385 DOI: 10.1074/Jbc.M112.435941 |
0.338 |
|
| 2013 |
Guo Y, Kenney SR, Romero E, Oprea T, Adams S, Muller C, Sklar L, Buranda T, Hudson L, Wandinger-Ness A. Abstract B81: Selected NSAIDs target GTPases for ovarian cancer therapy Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-B81 |
0.413 |
|
| 2013 |
Samudio-Ruiz SL, Hudson LG. Abstract B57: Continuous exposure to epidermal growth factor in ovarian cancer cells causes a persistent increase in N-cadherin expression which then results in multicellular aggregate compaction Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-B57 |
0.474 |
|
| 2012 |
King BS, Cooper KL, Liu KJ, Hudson LG. Poly(ADP-ribose) contributes to an association between poly(ADP-ribose) polymerase-1 and xeroderma pigmentosum complementation group A in nucleotide excision repair. The Journal of Biological Chemistry. 287: 39824-33. PMID 23038248 DOI: 10.1074/Jbc.M112.393504 |
0.755 |
|
| 2012 |
Samudio-Ruiz SL, Hudson LG. Increased DNA methyltransferase activity and DNA methylation following Epidermal Growth Factor stimulation in ovarian cancer cells. Epigenetics. 7: 216-24. PMID 22430797 DOI: 10.4161/Epi.7.3.19273 |
0.422 |
|
| 2012 |
Qin XJ, Liu W, Li YN, Sun X, Hai CX, Hudson LG, Liu KJ. Poly(ADP-ribose) polymerase-1 inhibition by arsenite promotes the survival of cells with unrepaired DNA lesions induced by UV exposure. Toxicological Sciences : An Official Journal of the Society of Toxicology. 127: 120-9. PMID 22387748 DOI: 10.1093/Toxsci/Kfs099 |
0.389 |
|
| 2012 |
Chavez MG, Buhr CA, Petrie WK, Wandinger-Ness A, Kusewitt DF, Hudson LG. Differential downregulation of e-cadherin and desmoglein by epidermal growth factor. Dermatology Research and Practice. 2012: 309587. PMID 22312325 DOI: 10.1155/2012/309587 |
0.785 |
|
| 2012 |
Kenney SR, Oprea T, Ursu O, Sklar L, Lomo L, Muller C, Gao Y, Wandinger-Ness A, Hudson L. Abstract 910: Selective inhibition of Rac1 and Cdc42 in ovarian cancer using the R-enantiomer of ketorolac Cancer Research. 72: 910-910. DOI: 10.1158/1538-7445.Am2012-910 |
0.389 |
|
| 2012 |
Samudio-Ruiz SL, Hudson LG. Abstract 4083: Increased DNA methyltransferase activity and DNA methylation following epidermal growth factor stimulation in ovarian cancer cells Cancer Research. 72: 4083-4083. DOI: 10.1158/1538-7445.Am2012-4083 |
0.428 |
|
| 2011 |
Zhou X, Sun X, Cooper KL, Wang F, Liu KJ, Hudson LG. Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs. The Journal of Biological Chemistry. 286: 22855-63. PMID 21550982 DOI: 10.1074/Jbc.M111.232926 |
0.31 |
|
| 2011 |
Burkhalter RJ, Symowicz J, Hudson LG, Gottardi CJ, Stack MS. Integrin regulation of beta-catenin signaling in ovarian carcinoma. The Journal of Biological Chemistry. 286: 23467-75. PMID 21518759 DOI: 10.1074/Jbc.M110.199539 |
0.432 |
|
| 2011 |
Wandinger-Ness A, Kenney SR, Agola J, Roxby J, Surviladze Z, Silberberg M, Zeineldin R, Vestling A, Bologa C, Ursu O, Oprea T, Muller C, Lomo L, Sklar L, Hudson LG. Abstract LB-214: Rac1 and Cdc42 GTPases as novel targets in ovarian cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-214 |
0.758 |
|
| 2010 |
Shirley SH, Hudson LG, He J, Kusewitt DF. The skinny on Slug. Molecular Carcinogenesis. 49: 851-61. PMID 20721976 DOI: 10.1002/Mc.20674 |
0.378 |
|
| 2010 |
Hudson LG, Gale JM, Padilla RS, Pickett G, Alexander BE, Wang J, Kusewitt DF. Microarray analysis of cutaneous squamous cell carcinomas reveals enhanced expression of epidermal differentiation complex genes. Molecular Carcinogenesis. 49: 619-29. PMID 20564339 DOI: 10.1002/Mc.20636 |
0.758 |
|
| 2010 |
Li Q, Lauer FT, Liu KJ, Hudson LG, Burchiel SW. Low-dose synergistic immunosuppression of T-dependent antibody responses by polycyclic aromatic hydrocarbons and arsenic in C57BL/6J murine spleen cells. Toxicology and Applied Pharmacology. 245: 344-51. PMID 20353797 DOI: 10.1016/J.Taap.2010.03.020 |
0.321 |
|
| 2010 |
Zeineldin R, Ning Y, Hudson LG. The constitutive activity of epidermal growth factor receptor vIII leads to activation and differential trafficking of wild-type epidermal growth factor receptor and erbB2. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 58: 529-41. PMID 20159766 DOI: 10.1369/Jhc.2010.955104 |
0.799 |
|
| 2010 |
Zeineldin R, Muller CY, Stack MS, Hudson LG. Targeting the EGF receptor for ovarian cancer therapy. Journal of Oncology. 2010: 414676. PMID 20066160 DOI: 10.1155/2010/414676 |
0.755 |
|
| 2009 |
Cowden Dahl KD, Dahl R, Kruichak JN, Hudson LG. The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia (New York, N.Y.). 11: 1208-15. PMID 19881956 DOI: 10.1593/Neo.09942 |
0.355 |
|
| 2009 |
Burchiel SW, Mitchell LA, Lauer FT, Sun X, McDonald JD, Hudson LG, Liu KJ. Immunotoxicity and biodistribution analysis of arsenic trioxide in C57Bl/6 mice following a 2-week inhalation exposure. Toxicology and Applied Pharmacology. 241: 253-9. PMID 19800901 DOI: 10.1016/J.Taap.2009.09.019 |
0.318 |
|
| 2009 |
Barbolina MV, Moss NM, Westfall SD, Liu Y, Burkhalter RJ, Marga F, Forgacs G, Hudson LG, Stack MS. Microenvironmental regulation of ovarian cancer metastasis. Cancer Treatment and Research. 149: 319-34. PMID 19763443 DOI: 10.1007/978-0-387-98094-2_15 |
0.356 |
|
| 2009 |
Hudson LG, Zeineldin R, Silberberg M, Stack MS. Activated epidermal growth factor receptor in ovarian cancer. Cancer Treatment and Research. 149: 203-26. PMID 19763438 DOI: 10.1007/978-0-387-98094-2_10 |
0.763 |
|
| 2009 |
Hudson LG, Newkirk KM, Chandler HL, Choi C, Fossey SL, Parent AE, Kusewitt DF. Cutaneous wound reepithelialization is compromised in mice lacking functional Slug (Snai2). Journal of Dermatological Science. 56: 19-26. PMID 19643582 DOI: 10.1016/J.Jdermsci.2009.06.009 |
0.303 |
|
| 2009 |
Moss NM, Liu Y, Johnson JJ, Debiase P, Jones J, Hudson LG, Munshi HG, Stack MS. Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen. Molecular Cancer Research : McR. 7: 809-20. PMID 19509114 DOI: 10.1158/1541-7786.Mcr-08-0571 |
0.411 |
|
| 2009 |
Cooper KL, Liu KJ, Hudson LG. Enhanced ROS production and redox signaling with combined arsenite and UVA exposure: contribution of NADPH oxidase. Free Radical Biology & Medicine. 47: 381-8. PMID 19414066 DOI: 10.1016/J.Freeradbiomed.2009.04.034 |
0.355 |
|
| 2009 |
Hudson LG, Moss NM, Stack MS. EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma. Future Oncology (London, England). 5: 323-38. PMID 19374540 DOI: 10.2217/Fon.09.10 |
0.451 |
|
| 2009 |
Sun X, Pi J, Liu W, Hudson LG, Liu KJ, Feng C. Induction of heme oxygenase 1 by arsenite inhibits cytokine-induced monocyte adhesion to human endothelial cells. Toxicology and Applied Pharmacology. 236: 202-9. PMID 19371606 DOI: 10.1016/J.Taap.2009.01.023 |
0.332 |
|
| 2009 |
Rodríguez-Fragoso L, Melendez K, Hudson LG, Lauer FT, Burchiel SW. EGF-receptor phosphorylation and downstream signaling are activated by benzo[a]pyrene 3,6-quinone and benzo[a]pyrene 1,6-quinone in human mammary epithelial cells. Toxicology and Applied Pharmacology. 235: 321-8. PMID 19166869 DOI: 10.1016/J.Taap.2008.12.022 |
0.43 |
|
| 2009 |
Zeineldin R, Al-Haik M, Hudson LG. Role of polyethylene glycol integrity in specific receptor targeting of carbon nanotubes to cancer cells. Nano Letters. 9: 751-7. PMID 19152309 DOI: 10.1021/Nl8033174 |
0.742 |
|
| 2009 |
Ding W, Liu W, Cooper KL, Qin XJ, de Souza Bergo PL, Hudson LG, Liu KJ. Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage. The Journal of Biological Chemistry. 284: 6809-17. PMID 19056730 DOI: 10.1074/Jbc.M805566200 |
0.383 |
|
| 2009 |
Kusewitt DF, Choi C, Newkirk KM, Leroy P, Li Y, Chavez MG, Hudson LG. Slug/Snai2 is a downstream mediator of epidermal growth factor receptor-stimulated reepithelialization. The Journal of Investigative Dermatology. 129: 491-5. PMID 18685621 DOI: 10.1038/Jid.2008.222 |
0.788 |
|
| 2008 |
Qin XJ, Hudson LG, Liu W, Ding W, Cooper KL, Liu KJ. Dual actions involved in arsenite-induced oxidative DNA damage. Chemical Research in Toxicology. 21: 1806-13. PMID 18707137 DOI: 10.1021/Tx8001548 |
0.332 |
|
| 2008 |
Ding W, Hudson LG, Sun X, Feng C, Liu KJ. As(III) inhibits ultraviolet radiation-induced cyclobutane pyrimidine dimer repair via generation of nitric oxide in human keratinocytes. Free Radical Biology & Medicine. 45: 1065-72. PMID 18621123 DOI: 10.1016/J.Freeradbiomed.2008.06.022 |
0.396 |
|
| 2008 |
Qin XJ, Hudson LG, Liu W, Timmins GS, Liu KJ. Low concentration of arsenite exacerbates UVR-induced DNA strand breaks by inhibiting PARP-1 activity. Toxicology and Applied Pharmacology. 232: 41-50. PMID 18619636 DOI: 10.1016/J.Taap.2008.05.019 |
0.348 |
|
| 2008 |
Cowden Dahl KD, Symowicz J, Ning Y, Gutierrez E, Fishman DA, Adley BP, Stack MS, Hudson LG. Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Research. 68: 4606-13. PMID 18559505 DOI: 10.1158/0008-5472.Can-07-5046 |
0.635 |
|
| 2008 |
Hudson LG, Zeineldin R, Stack MS. Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression. Clinical & Experimental Metastasis. 25: 643-55. PMID 18398687 DOI: 10.1007/S10585-008-9171-5 |
0.754 |
|
| 2008 |
Newkirk KM, MacKenzie DA, Bakaletz AP, Hudson LG, Kusewitt DF. Microarray analysis demonstrates a role for Slug in epidermal homeostasis. The Journal of Investigative Dermatology. 128: 361-9. PMID 17637818 DOI: 10.1038/Sj.Jid.5700990 |
0.383 |
|
| 2007 |
Cowden Dahl KD, Zeineldin R, Hudson LG. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells. Molecular Cancer Research : McR. 5: 413-21. PMID 17475671 DOI: 10.1158/1541-7786.Mcr-07-0019 |
0.761 |
|
| 2007 |
Symowicz J, Adley BP, Gleason KJ, Johnson JJ, Ghosh S, Fishman DA, Hudson LG, Stack MS. Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Research. 67: 2030-9. PMID 17332331 DOI: 10.1158/0008-5472.Can-06-2808 |
0.384 |
|
| 2007 |
Hudson LG, Choi C, Newkirk KM, Parkhani J, Cooper KL, Lu P, Kusewitt DF. Ultraviolet radiation stimulates expression of Snail family transcription factors in keratinocytes. Molecular Carcinogenesis. 46: 257-68. PMID 17295233 DOI: 10.1002/Mc.20257 |
0.469 |
|
| 2007 |
Cooper KL, Liu KJ, Hudson LG. Contributions of reactive oxygen species and mitogen-activated protein kinase signaling in arsenite-stimulated hemeoxygenase-1 production. Toxicology and Applied Pharmacology. 218: 119-27. PMID 17196236 DOI: 10.1016/J.Taap.2006.09.020 |
0.396 |
|
| 2007 |
Ning Y, Buranda T, Hudson LG. Activated epidermal growth factor receptor induces integrin alpha2 internalization via caveolae/raft-dependent endocytic pathway. The Journal of Biological Chemistry. 282: 6380-7. PMID 17179151 DOI: 10.1074/Jbc.M610915200 |
0.641 |
|
| 2006 |
Zeineldin R, Rosenberg M, Ortega D, Buhr C, Chavez MG, Stack MS, Kusewitt DF, Hudson LG. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III. Molecular Carcinogenesis. 45: 851-60. PMID 16788982 DOI: 10.1002/Mc.20237 |
0.786 |
|
| 2006 |
Zeineldin R, Hudson LG. Epithelial cell migration in response to epidermal growth factor. Methods in Molecular Biology (Clifton, N.J.). 327: 147-58. PMID 16780219 DOI: 10.1385/1-59745-012-X:147 |
0.77 |
|
| 2005 |
Ding W, Hudson LG, Liu KJ. Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Molecular and Cellular Biochemistry. 279: 105-12. PMID 16283519 DOI: 10.1007/S11010-005-8227-Y |
0.328 |
|
| 2005 |
Ning Y, Zeineldin R, Liu Y, Rosenberg M, Stack MS, Hudson LG. Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation. Cancer Research. 65: 9280-6. PMID 16230389 DOI: 10.1158/0008-5472.Can-05-0407 |
0.807 |
|
| 2005 |
Symowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG, Stack MS. Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Research. 65: 2234-42. PMID 15781636 DOI: 10.1158/0008.5472.Can-04-2781 |
0.475 |
|
| 2005 |
Savagner P, Kusewitt DF, Carver EA, Magnino F, Choi C, Gridley T, Hudson LG. Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes. Journal of Cellular Physiology. 202: 858-66. PMID 15389643 DOI: 10.1002/Jcp.20188 |
0.374 |
|
| 2004 |
Cooper KL, Myers TA, Rosenberg M, Chavez M, Hudson LG. Roles of mitogen activated protein kinases and EGF receptor in arsenite-stimulated matrix metalloproteinase-9 production. Toxicology and Applied Pharmacology. 200: 177-85. PMID 15504454 DOI: 10.1016/J.Taap.2004.04.023 |
0.777 |
|
| 2004 |
Shi H, Hudson LG, Ding W, Wang S, Cooper KL, Liu S, Chen Y, Shi X, Liu KJ. Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chemical Research in Toxicology. 17: 871-8. PMID 15257611 DOI: 10.1021/Tx049939E |
0.322 |
|
| 2003 |
Burdick AD, Davis JW, Liu KJ, Hudson LG, Shi H, Monske ML, Burchiel SW. Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. Cancer Research. 63: 7825-33. PMID 14633709 |
0.317 |
|
| 2001 |
Gaudry CA, Palka HL, Dusek RL, Huen AC, Khandekar MJ, Hudson LG, Green KJ. Tyrosine-phosphorylated Plakoglobin is Associated with Desmogleins but not Desmoplakin after Epidermal Growth Factor Receptor Activation Journal of Biological Chemistry. 276: 24871-24880. PMID 11335725 DOI: 10.1074/Jbc.M102731200 |
0.389 |
|
| 2000 |
McCawley LJ, Li S, Benavidez M, Halbleib J, Wattenberg EV, Hudson LG. Elevation of intracellular cAMP inhibits growth factor-mediated matrix metalloproteinase-9 induction and keratinocyte migration. Molecular Pharmacology. 58: 145-51. PMID 10860936 DOI: 10.1124/Mol.58.1.145 |
0.427 |
|
| 1998 |
Hudson LG, McCawley LJ. Contributions of the epidermal growth factor receptor to keratinocyte motility. Microscopy Research and Technique. 43: 444-455. PMID 9858341 DOI: 10.1002/(Sici)1097-0029(19981201)43:5<444::Aid-Jemt10>3.0.Co;2-C |
0.459 |
|
| 1998 |
Ellerbroek SM, Hudson LG, Stack MS. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion. International Journal of Cancer. Journal International Du Cancer. 78: 331-7. PMID 9766568 DOI: 10.1002/(Sici)1097-0215(19981029)78:3<331::Aid-Ijc13>3.0.Co;2-9 |
0.465 |
|
| 1997 |
McCawley LJ, O'Brien P, Hudson LG. Overexpression of the Epidermal Growth Factor Receptor Contributes to Enhanced Ligand-Mediated Motility in Keratinocyte Cell Lines1. Endocrinology. 138: 121-127. PMID 28200148 DOI: 10.1210/endo.138.1.4844 |
0.318 |
|
| 1996 |
Cha D, O'Brien P, O'Toole EA, Woodley DT, Hudson LG. Enhanced Modulation of Keratinocyte Motility by Transforming Growth Factor-α (TGF-α) Relative to Epidermal Growth Factor (EGF) Journal of Investigative Dermatology. 106: 590-597. PMID 8617990 DOI: 10.1111/1523-1747.Ep12345083 |
0.425 |
|
| 1989 |
Hudson LG, Santon JB, Gill GN. Regulation of epidermal growth factor receptor gene expression. Molecular Endocrinology (Baltimore, Md.). 3: 400-8. PMID 2540431 DOI: 10.1210/mend-3-2-400 |
0.345 |
|
| 1986 |
Hudson LG, Toscano WA, Greenlee WF. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) modulates epidermal growth factor (EGF) binding to basal cells from a human keratinocyte cell line. Toxicology and Applied Pharmacology. 82: 481-92. PMID 3952731 DOI: 10.1016/0041-008X(86)90283-8 |
0.647 |
|
| 1985 |
Greenlee WF, Osborne R, Dold KM, Hudson LG, Toscano WA. Toxicity of chlorinated aromatic compounds in animals and humans: in vitro approaches to toxic mechanisms and risk assessment. Environmental Health Perspectives. 60: 69-76. PMID 2992929 DOI: 10.1289/Ehp.856069 |
0.631 |
|
| 1985 |
Hudson LG, Toscano WA, Greenlee WF. Regulation of epidermal growth factor binding in a human keratinocyte cell line by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology. 77: 251-9. PMID 2579474 DOI: 10.1016/0041-008X(85)90324-2 |
0.635 |
|
| 1983 |
Hudson LG, Shaikh R, Toscano WA, Greenlee WF. Induction of 7-ethoxycoumarin o-deethylase activity in cultured human epithelial cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): evidence for TCDD receptor. Biochemical and Biophysical Research Communications. 115: 611-7. PMID 6312985 DOI: 10.1016/S0006-291X(83)80188-0 |
0.624 |
|
| Show low-probability matches. |